All News

sss

Zometa linked to osteonecrosis of the jaw

Problem: The Food & Drug Administration would like to alert healthcare providers to medication errors involving confusion between Metadate ER and Metadate CD. Practitioners should be cautious when

It is estimated that symptoms of attention deficit/hyperactivity disorder (ADHD) persist into adulthood in 50% to 60% of those diagnosed with the condition in childhood and adolescence. According to researchers, more than eight million adults in the United States have ADHD .

CMS revises ASP calculation for Medicare Part B

R.Ph.s react to new overtime regs

Truvada from Gilead is a new drug just approved for HIV.

Breaking News for Sept. 13, 2004

R.Ph.s react to new overtime regs

Stockchecker on antacids.

The painful physical symptoms of depression often go unrecognized and/or untreated, although 69% of those with the condition list physical symptoms as the main reason for a visit to their primary care physician. Fortunately, clinicians can now offer patients with depression an agent that addresses both depressed mood and common physical symptoms, such as back pain. The FDA recently approved duloxetine (Cymbalta, Eli Lilly) capsules for the treatment of Major Depressive Disorder. The drug is currently available in pharmacies.

An association for buying groups issues guidelines for hospitals on how to cope with drug shortages

Kopp drug opens 10th store in PA and carves niche in gifts and cards

New Kaiser study finds elderly confused by Medicare law, but association for pharmacy benefit managers disputes the findings

Case studies are given of patients who suffered errors related to radiology and radiological procedures.

The author believes that state boards of pharmacy should take steps to address pharmacists' heavy workload in the interest of patient safety

One hospital has developed an effective way to handle drug shortages with computerized alerts.

Consumers can get better comparisons of hospitals and other health facilities on the Web through JCAHO program

generic drug pricing

Breaking News for Aug. 23, 2004

The Department of Health & Human Services unveiled proposed regulations governing the Medicare Part D prescription drug benefit slated to debut in January 2006.

Medicine Shoppe International offers franchisees a new contract that reduces royalty fees but sparks controversy.

Web conference on growing threat of counter drugs and danger of importation

CMS holds meeting to discuss the establishment of regions for Medicare Part D

This installment addresses administrative security requirements

Vytorin has been approved as adjunctive therapy to diet for reduction of elevated total cholesterol.

Combination products make treatment regimens for HIV/AIDS easier to follow, because such regimens often require the simultaneous use of 3 or more drugs from different classes. The FDA recently approved abacavir/lamivudine (Epzicom, GlaxoSmithKline) 600 mg/300 mg tablets for the treatment of HIV infection. The drug will be available in U.S. pharmacies by the end of August or in early September.